Tracking Glucose and Activity to Reduce Sitting in Older Adults With Type 2 Diabetes
Tests glucose and activity trackers to help older adults with type 2 diabetes sit less.
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Registry title
- Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- 12 May 2026
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional
- Treatments tested
- SB Intervention
- Record updated
- 4 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 55 and older who have had type 2 diabetes for at least 5 years. It studies how they use glucose monitor and activity data to sit less.
- Age
- 55 years and older
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes, reported by the person, for 5 years or more.
- Earlier treatment
- Cannot have used a continuous glucose monitor (CGM) for 1 month or more in the past year.
Main reasons for not taking part
- Type 1 diabetes
- Dementia
- Not willing to use or wear the CGM, activPAL, or Fitbit
- Severe lung disease, severe osteoarthritis, or class III/IV heart failure
- Needing a wheelchair or walker
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Aged 55 years and older
- Self-reported T2D for ≥5 years
- Speak and read English
Who cannot take part
- Type 1 diabetes
- Dementia
- Any of the following conditions that may impact SB:; Severe pulmonary disease; Severe osteoarthritis; Class III/IV heart failure; Require wheelchair or walker
- Use of a CGM for ≥1 month in past 1 year
- Not willing to use/wear the CGM, activPAL, or Fitbit
Where in United States
- University of MinnesotaMinneapolis, United StatesContact: Mary Whipple, PhD, RN, PHN, FSVM, FAHATaking people
About the trial
What the trial wants to find out
The overarching goal of this explanatory mixed methods study is to evaluate how older people living with type 2 diabetes (T2D) integrate continuous glucose monitor (CGM) and activity data in diabetes self-management, and how this technology supports reduced sedentary behavior (SB) and improved glucose control.
The group in the trial
- SB InterventionTreatment being tested
10-day self-monitoring and reminders of sedentary behavior, followed by 30 days of activity monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)
- Plain-language title
- Tracking Glucose and Activity to Reduce Sitting in Older Adults With Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 4 June 2026